Full Text View
Tabular View
No Study Results Posted
Related Studies
The Effects of Very Early Use of Rosuvastatin in Preventing Recurrence of Ischemic Stroke (EUREKA)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2010 by Severance Hospital.
Recruitment status was  Recruiting
Study NCT01364220   Information provided by Severance Hospital

First Received on May 26, 2011.   Last Updated on July 20, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Stroke
Additional conditions recognized in this trial
Cerebral Infarction
Recurrence
More general conditions related to this trial
Brain Diseases
Brain Infarction
Brain Ischemia
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Disease Attributes
Nervous System Diseases
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
Rosuvastatin
Placebo: Sugar pill
Additional drug interventions recognized in this trial
Hydroxymethylglutaryl-CoA Reductase Inhibitors
More general drug interventions related to this trial
Anticholesteremic Agents
Antimetabolites
Enzyme Inhibitors
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Severance Hospital
AstraZeneca


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services